Log in
RegisterReasonability of MR formulations [Bioanalytics]
posted by Helmut 
– Vienna, Austria, 2009-07-06 20:51 (6201 d 16:46 ago) – Posting: # 3934
Views: 3,597
Dear Daniel!
Exactly. But not everything in the world of big pharma is driven by science.
I once came across a drug, where the innovator got his first market authorization with a modified release formulation despite a half-live of two days. Obviously this was just done to make the life of generic companies miserable (it’s much more difficult to demonstrate BE of an MR formulation).
❝ [...] Due this long half life a modified release formulation is not necessary.
Exactly. But not everything in the world of big pharma is driven by science.
I once came across a drug, where the innovator got his first market authorization with a modified release formulation despite a half-live of two days. Obviously this was just done to make the life of generic companies miserable (it’s much more difficult to demonstrate BE of an MR formulation).—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
Helmut Schütz
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- leflunomide extended release baxivishal 2009-07-06 15:49
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- leflunomide extended release Helmut 2009-07-06 16:35
- leflunomide extended release drcampos 2009-07-06 18:41
- Reasonability of MR formulationsHelmut 2009-07-06 18:51
- Reasonability of MR formulations drcampos 2009-07-07 19:45
- Reasonability of MR formulationsHelmut 2009-07-06 18:51
Ing. Helmut Schütz